Bioventus Inc. ( BVS) - Stock Earnings
BVS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
BVS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 14.8 million USD | 157.9 million USD |
| 2026Q1 | 3.1 million USD | 132.1 million USD |
| 2026Q2 | 33.4 million USD | 153.2 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
BVS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -156.2 million USD | 512.3 million USD |
| 2024 | -33.5 million USD | 573.3 million USD |
| 2025 | 22.7 million USD | 568.1 million USD |
| 2026 Est. | — | — |
BVS
Price: $13.53
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.77 USD
P/E Ratio: 18.13
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 889.5 million